WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

In winter, various respiratory infectious diseases such as influenza (flu), pneumonia, and COVID-19 are prevalent at the same ...

WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...

Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

WHO has prequalified two Covid-19 rapid antigen tests for the first time, confirming long-term quality and enabling UN ...

WHO has prequalified two rapid COVID-19 antigen tests, confirming their safety and quality and expanding access to fast, ...

TrinScreen HIV order signals renewed strength in global HIV testing market- Company also reports a key milestone of Adjusted EBITDA1positive ...

A 29-year-old woman was referred to Tufts Medical Center for undifferentiated bilateral anterior and intermediate uveitis.The ...

Pests that spread as a result of climate change pose an increasing threat to fruit farming and viticulture in Germany. Fraunhofer researchers are working with partners to develop methods for the early ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA1positive operations in Q3 2025 and expects to achieve strong additi ...